Objective: To examine whether risk factor profile, baseline features, and outcome of cervical artery dissection (CEAD) differ according to the dissection site.
to the aortic segment concerned, 5 ICAD and VAD may have distinct underlying mechanisms and characteristics.
Our aim was to compare the distribution of putative risk factors, clinical and radiologic presentation, and short-term outcome in patients with ICAD and patients with VAD in the Cervical Artery Dissection and Ischemic Stroke Patients (CADISP) study, a large multicenter cohort of consecutive patients with CEAD.
METHODS Study population. Structure and methods of the CADISP study have been described in detail previously. 6 Between 2004 and 2009, as part of a multicenter effort comprising 20 centers in 9 countries, we have included consecutive patients evaluated in a department of neurology with a diagnosis of CEAD or a diagnosis of IS of another cause than CEAD (non-CEAD IS). Patients were recruited both prospectively and retrospectively. Retrospective patients are participants who had a qualifying event before the beginning of the study in each center and were identified through local registries of patients with CEAD. The vast majority of patients had a qualifying event between 1999 and 2009 (Ͻ4% before 1999). The primary aim of the CADISP consortium was to perform a genetic association study, currently underway, to identify genetic susceptibility factors of CEAD. 6 All but 2 centers also participated in an observational clinical study including detailed screening of putative environmental risk factors, clinical and radiologic characteristics, and 3-month outcome (assessed as part of the standard outpatient follow-up of young patients in each center), using a standardized questionnaire. The CADISP clinical study comprises a total of 983 patients with a diagnosis of CEAD and 658 patients with a diagnosis of non-CEAD IS frequency matched on age (by 5-year intervals) and gender, included in 8 countries (Argentina, Belgium, Finland, France, Germany, Italy, Switzerland, Turkey) and 18 centers (figure e-1 on the Neurology ® Web site at www.neurology.org). Only patients with a diagnosis of CEAD were included in the present analysis. Detailed inclusion criteria are available online (figure e-2). Briefly, patients with CEAD had to present a mural hematoma, aneurysmal dilatation, long tapering stenosis, intimal flap, double lumen or occlusion Ͼ2 cm above the carotid bifurcation revealing an aneurysmal dilation, or a long tapering stenosis after recanalization, in a cervical artery (internal carotid or vertebral); purely intracranial or iatrogenic dissections were not included. Of the 983 patients with a diagnosis of CEAD we excluded one patient who sustained a dissection of the common carotid and subclavian artery (neither ICAD nor VAD); for most analyses, except secondary analyses on multisite dissections, we also excluded 36 patients who had sustained both an ICAD and a VAD. Hence the sample size for the main analyses was 946 patients, 619 with 1 or 2 ICAD and 327 with 1 or 2 VAD (figure e-3).
Variable definition. Putative risk factors. We examined the prevalence (at the time of the qualifying event) of clinical parameters that were previously shown to be associated with an increased risk (hypertension, 7-9 cervical trauma, 10,11 recent infection, 12-14 migraine 15, 16 ) or a reduced risk (elevated body mass index [BMI], 9,17 hypercholesterolemia 9 ) of CEAD. We defined vascular risk factors as follows: hypertension, by a history of elevated blood pressure (systolic blood pressure Ն140 mm Hg or diastolic blood pressure Ն90 mm Hg) diagnosed by the treating physician, or use of a blood pressure-lowering therapy; hypercholesterolemia, by a fasting total cholesterol Ն6.20 mmol/L or fasting low-density lipoprotein cholesterol Ն4.1 mmol/L, measured within 48 hours after admission or diagnosed by the treating physician, or use of a cholesterol-lowering therapy; and BMI as the ratio of weight (kg) to the square of height (m 2 ). Migraine was defined according to the International Classification of Headache Disorders. 18 An infection in the week preceding the dissection corresponded to the presence of at least one typical symptom of infection, in combination with fever (temperature Ն38°C) or the presence of at least one typical symptom of infection with corresponding serologic, culture, or radiologic findings indicating an acute infection or the combination of at least 2 typical corresponding symptoms. 19 We categorized cervical trauma in the month preceding the dissection as severe if leading to a medical visit or hospitalization, and as minor otherwise. We also recorded the presence or absence of a history of CEAD.
Clinical presentation. Presence or absence of cerebral or retinal ischemia (ischemic stroke, TIA, or transient monocular blindness) and of cervical pain or headache at admission were recorded. For patients who sustained an ischemic stroke, we computed the NIH Stroke Scale (NIHSS) score at admission, as a marker of initial stroke severity.
Radiologic presentation. We recorded the following radiologic features on the dissected arteries at admission: arterial occlusion, defined by the absence of blood flow; stenosis, defined by a narrowing of the arterial lumen, regardless of the presence or absence of hemodynamic blood flow modifications; aneurysmal dilatation, defined by a focal enlargement of the arterial lumen and external diameter; mural hematoma, defined by eccentric thickening of the arterial wall with imaging characteristics compatible with acute or subacute bleeding within the thickened wall; multiple dissections, defined by the simultaneous presence of a recent dissection on more than one cervical artery.
Short-term outcome. We rated the 3-month functional outcome according to the modified Rankin Scale (mRS), 20 and recorded recurrent CEAD and stroke or TIA within 3 months after admission.
Statistical analyses. We compared risk factors and clinical
and radiologic characteristics between patients with ICAD and patients with VAD, using Student t test for continuous variables and a 2 test for categorical variables (or Fisher exact test when appropriate). In addition, we ran a multivariable logistic regression adjusted for age, gender, and country of inclusion. For clinical and radiologic characteristics, we also adjusted for risk factors that we found to be associated with dissection site (ICAD vs VAD), in a secondary analysis.
To explore the association of dissection site with 3-month functional outcome in patients who had sustained an IS at admission, we dichotomized the mRS score into 0 -2 vs 3-5, and ran a multivariable logistic regression, where the dissection site was the main predictor variable. The primary model was adjusted for age, gender, and country of inclusion. In a secondary model, we additionally adjusted for the NIHSS score at admission. We also examined the relation of dissection site with recurrent CEAD and stroke or TIA at 3 months, using a multivariable logistic regression adjusted for age, gender, and country of inclusion.
As a sensitivity analysis, all models were adjusted for the delay between the qualifying event (first clinical signs) and inclu-sion to account for a potential recall bias in patients included several weeks or months after the dissection occurred.
Analyses were performed using Statistical Analyses System ® software version 9.2 (SAS Institute, Cary, NC).
RESULTS Putative risk factor distribution.
Patients with ICAD were significantly older compared to patients with VAD (table 1) . While VAD occurred at a similar frequency in men and women, patients with ICAD were more often men (table 1 ). An infection in the week preceding the dissection was more often reported in patients with ICAD; a minor cervical trauma in the previous month was more common in patients with VAD, although this result reached only borderline significance in the multivariable model (table  1) . The results were unchanged when additionally adjusting for the delay of inclusion (data not shown).
Clinical presentation and radiologic features.
Cervical pain was about twice as common in patients with VAD, while headache at admission was slightly more frequent in patients with ICAD (table 2) . Cerebral ischemia, and specifically IS, was significantly more frequent at admission in VAD than in ICAD. Among patients with an IS, the NIHSS score at admission was higher in patients with ICAD than in patients with VAD. Aneurysmal dilatation was more Abbreviations: BMI ϭ body mass index; CEAD ϭ cervical artery dissection; CI ϭ confidence interval; ICAD ϭ internal carotid artery dissection; OR ϭ odds ratio; VAD ϭ vertebral artery dissection. a Univariate. b Adjusted for age and gender, except the first 2 lines, and inclusion country (the probability modeled is ICAD vs VAD). c For patients with ICAD, non-European origin was Hispanic (n ϭ 1), North African (n ϭ 1), or unknown (n ϭ 2); for patients with VAD, non-European origin was mixed Caribbean and Mauritian (n ϭ 3), North African (n ϭ 2), South African (n ϭ 1), South Asian (n ϭ 1), and Middle Eastern (n ϭ 1). Abbreviations: CI ϭ confidence interval; ICAD ϭ internal carotid artery dissection; NIHSS ϭ NIH Stroke Scale; OR ϭ odds ratio; TMB ϭ transient monocular blindness; VAD ϭ vertebral artery dissection. a Univariate. b Adjusted for age, gender, and inclusion country (the probability modeled is ICAD vs VAD). c Among patients with an ischemic stroke at admission in whom the NIHSS score was available (n ϭ 208 VAD ͓82.5% of VAD cases with ischemic stroke͔ and n ϭ 291 ICAD ͓78.0% of ICAD cases with ischemic stroke͔).
often seen in patients with ICAD, while the distribution of arterial occlusion, stenosis, and mural hematoma did not differ significantly ( , p ϭ 0.09). Twenty-six patients (2.9%) had a stroke or TIA within 3 months after admission (16 had a stroke, 8 a TIA, and 2 both), which was associated with concomitant CEAD recurrence in 2 patients (both of whom had a TIA). In 23 patients this was a recurrent ischemic event, and in 3 a first ischemic event. There was no significant difference in the rate of stroke or TIA within 3 months after admission between patients with ICAD and patients with VAD (OR ϭ 1.82 [0.71-4.67], p ϭ 0.21). Adjusting for the delay of inclusion did not modify these associations (data not shown).
DISCUSSION
In a large multicenter sample of almost 1,000 patients with CEAD, we found that patients with ICAD were older than patients with VAD and more often men; they more frequently experienced an infection in the week preceding the dissection, while patients with VAD more often reported a minor cervical trauma in the previous month. Patients with VAD more commonly complained of cervical pain and had a higher prevalence of bilateral dissection and cerebral ischemia at admission, while patients with ICAD more often showed aneurysmal dilatation on arterial imaging. Among patients who sustained an IS, patients with ICAD were more severely affected at admission and more likely to have an unfavorable functional 3-month outcome. Recurrent CEAD events at 3 months were rare and tended to be more common in ICAD.
Few studies have compared risk factors, baseline characteristics, and outcome between patients with ICAD and patients with VAD, in single-center series of limited sample size. 3, [21] [22] [23] Recent cervical manipulation was significantly more common in patients with VAD than patients with ICAD in a singlecenter series of 126 patients with CEAD. 21 While cerebral infarction on neuroimaging was significantly more common in patients with VAD than patients with ICAD in a small community-based cohort, 3 only trends toward a higher frequency of clinical stroke in VAD were reported. 3, 21, 23 One previous report suggested that VADs are more often bilateral. 21 The significantly higher prevalence of aneurysmal dilatation that we observed in patients with ICAD compared to patients with VAD has not been reported previously to our knowledge, although a similar trend was suggested before. 23, 24 A better functional outcome in patients with VAD compared to patients with ICAD had been reported in an earlier series. 25 The fact that this association disappeared here after adjusting for initial stroke severity is in line with previous data showing that baseline NIHSS score is the main independent predictor of poor functional outcome in patients with IS. 26 The low rate of ischemic events after admission and of recurrent dissections at 3 months both in patients with VAD and patients with ICAD is in agreement with previous observations reporting low recurrence rates in the first months following the index event. 27 If confirmed in independent datasets, some of the differences we observed between VAD and ICAD characteristics could suggest that the mechanisms might partly differ according to the dissection site, although these are hypotheses. The younger age of patients with VAD could suggest that age-related risk factors differentially affect the risk of VAD and ICAD, while the overrepresentation of men among patients with ICAD could perhaps be related to gender-specific hormonal or genetic risk factors of ICAD. 28 The slightly higher prevalence of minor cervical traumas preceding VAD compared to ICAD could be partly accounted for by anatomic features. Indeed, the carotid artery is essentially mobile in its cervical trajectory and protected by muscular and adipose tissue layers, while the vertebral artery is anchored to the cervical spine which could render it more vulnerable to mechanical solicitations. The higher prevalence of recent infection in patients with ICAD compared to patients with VAD could reflect that endothelial damage, prothrombotic state, and protease activation, which are thought to underlie the association between infection and CEAD, 29 -32 might be more likely to occur in close proximity of the infection, as carotid arteries are anatomically closer to the upper respiratory tract. 33 Future studies could examine the association of recent infection with ICAD and VAD stratified on the infection type (e.g., upper respiratory tract vs other). As patients with ICAD more frequently had cerebral ischemia and more often had an aneurysmal dilatation, one could speculate that dissections in the internal carotid artery could more often be subadventitial, expanding externally, while dissections in the vertebral artery could more often be subintimal, expanding toward the arterial lumen, thus leading to a higher frequency of ischemic events. 34 Interestingly, a high intrafamilial correlation between the affected vessel (internal carotid or vertebral) was observed in familial forms of CEAD. 35 Furthermore, pericytes and smooth muscle cells in carotid arteries are derived from the neural crest, whereas vertebral arteries emerge exclusively from the mesoderm. 36 This could suggest that distinct genetic and developmental factors may be involved in the occurrence of ICAD and VAD, in analogy with aortic dissection where pathogenesis differs between the proximal or distal aortic segment, which also have distinct embryonic origins and inheritance patterns. 5, 37 The main strengths of this project are the large sample size and the standardized collection of extensive clinical information. The partly retrospective recruitment may have biased the assessment of risk factors present prior to the qualifying event; however, adjusting for the delay between qualifying event and inclusion in the study did not modify the associations. The frequency of infection in the previous week may be an overestimation given the broad definition we have used, but both groups were subject to the same bias. Our patients were recruited through neurology departments, mostly in tertiary centers, thus patients with CEAD with local signs only or with minor cerebral or retinal ischemia, as well as patients with very severe strokes requiring intensive care, were less likely to be included. Since the clinical presentation of single VAD can be mild and unspecific, ascertainment of patients with VAD could be biased toward individuals with bilateral VAD, who have more conspicuous symptoms. In addition, patients experiencing VAD without cerebral ischemia usually have unspecific symptoms that are more likely to be misdiagnosed, which could have inflated the proportion of patients with VAD with cerebral ischemia in our sample. Cervical pain or other symptoms whose detection relies on the patient's report may have been underestimated in patients with ICAD, as aphasia is more frequent in patients with cerebral ischemia in the carotid territory. Finally, we did not perform any correction for multiple testing as we considered our study as exploratory. Our findings, some of which were only moderate in terms both of strength of association and effect size, require confirmation in independent cohorts.
Our observations suggest that, in analogy with the aorta where there is heterogeneity in the characteristics and mechanisms of aortic disease according to the segment involved, cervical artery dissections have distinct features according to the type of artery affected. Research on the pathophysiology, risk factors (including genetic susceptibility factors), and outcome of CEAD should take into account the dissection site, as pooled analyses could fail to identify important site-specific determinants.
In the largest multicenter series of patients with CEAD, we describe significant differences between VAD and ICAD in terms of putative risk factors, baseline characteristics, and short-term functional outcome.
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